Linzolid (Tablet 600 mg)

Linzolid is indicated for the treatment of: Nosocomial pneumonia Community-acquired pneumonia Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis Uncomplicated skin and skin structure infections Vancomycin-resistant Enterococcus faecium infections Limitations of use: Linzolid is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Linzolid given for longer than 28 days have not been evaluated in controlled clinical trials. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart